Lowe’s Flavocure secures US patent for ganja eye drug
myiaj_admin2019-05-17T13:13:26+00:00Flavocure Biotech, a cannabis research company that is majority owned by Dr Henry Lowe, has received approval from the US Patent Office for a drug that treats glaucoma and myopia, or nearsightedness. According to the patent issued on May 7, both Lowe and Flavocure CEO Dr Ngeh Toyang are listed